July 31, 2014 7:48 PM ET


Company Overview of IBSA Institut Biochimique S.A.

Company Overview

IBSA Institut Biochimique S.A., a pharmaceutical company, manufactures and sells hormones, soft gel capsules, and finished products worldwide. The company was founded in 1945 and is headquartered in Lugano, Switzerland with manufacturing sites in Italy and China.

Via del piano

Lugano,  6915


Founded in 1945


41 58 360 10 00


41 58 360 16 77

Key Executives for IBSA Institut Biochimique S.A.

IBSA Institut Biochimique S.A. does not have any Key Executives recorded.

IBSA Institut Biochimique S.A. Key Developments

IBSA Institut Biochimique S.A. Presents at BIO-Europe 2012, Nov-12-2012

IBSA Institut Biochimique S.A. Presents at BIO-Europe 2012, Nov-12-2012 . Venue: CCH Congress Center Hamburg, Am Dammtor / Marseiller Str, 20355 Hamburg, Germany.

Cipher Pharmaceuticals, Inc. Reaches In-License Agreement with IBSA Institut Biochimique S.A. for the Betesil Patch to Treat Inflammatory Skin Conditions

Cipher Pharmaceuticals Inc. announced it has reached agreement with IBSA Institut Biochimique S.A., to obtain exclusive license and distribution rights in Canada to market the Betesil Patch, a novel, patent-protected, self-adhesive medicated plaster containing 0.1% betamethasone valerate, for the treatment of inflammatory skin conditions such as plaque psoriasis. The Betesil Patch is an innovative new pharmaceutical approach to the treatment of inflammatory skin conditions. Based on initial feedback from Canadian dermatologists, the Betesil Patch is expected to provide distinct advantages over existing treatment options, particularly for patients that suffer from plaque psoriasis in hard to treat areas such as knees and elbows. The efficacy and safety of the Betesil Patch has been established in three phase III trials conducted by IBSA. The product is currently marketed in several European countries. Cipher intends to initiate the regulatory review process for the Betesil Patch in Canada in fourth quarter of this year. The financial terms of the agreement include an upfront fee of CAD 100,000, followed by other regulatory related milestone payments. Commercial product will be supplied by IBSA.

Similar Private Companies By Industry

Company Name Region
Biocon SA Europe
Johnson & Johnson AG Europe
Dr. E. Gräub AG Europe
Lurgi TPS AG Europe
IBSA Institut Biochimique S.A. Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IBSA Institut Biochimique S.A., please visit www.ibsa-ch.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.